Comac Medical has conducted an assessment in IMP³rove – an instrument provided by the European Commission for measurement of the innovation potential of the company, which ranked the company among the growth champions in Europe.
IMP³rove assessment
October 19, 2015
Share:
News
Summer brings sunlit days, long evenings, and countless opportunities to enjoy the outdoors. Yet for the pharmaceutical and...
[Sofia, Bulgaria] – Comac Medical is pleased to announce the publication of a new scientific article, co-authored by Professor...
Clinical trial supply management is a critical function in the execution of successful clinical trials. From forecasting and...